ホームBBN • SWX
Bellevue Group AG
CHF 13.50
1月28日, 14:36:24 GMT+1 · CHF · SWX · 免責条項
株式CH 上場銘柄
前日の終値
CHF 14.10
日次変動幅
CHF 13.50 - CHF 14.15
年間変動幅
CHF 11.05 - CHF 24.30
時価総額
1.82億 CHF
平均取引高
9331.00
株価収益率
12.18
配当利回り
8.52%
優先市場
SWX
市場ニュース
財務情報
損益計算書
収益
純利益
(CHF)2024年6月前年比変化率
収益
1840.80万-11.31%
営業費用
1373.15万-10.56%
純利益
371.50万-7.22%
純利益率
20.184.61%
1 株当たりの収益
EBITDA
実効税率
17.26%
総資産
負債総額
(CHF)2024年6月前年比変化率
現金および短期投資
3048.80万100.63%
総資産
1.39億-4.69%
負債総額
2204.90万-24.81%
純資産
1.17億
発行済み株式
1320.15万
帳簿価格
1.60
総資産利益率
10.71%
資本利益率
現金の純増減額
(CHF)2024年6月前年比変化率
純利益
371.50万-7.22%
営業キャッシュ フロー
365.20万137.31%
投資キャッシュ フロー
財務キャッシュ フロー
-810.25万45.85%
現金の純増減額
-417.30万83.13%
フリー キャッシュ フロー
概要
Bellevue Group AG, headquartered in Zurich, is a listed investment management corporation from Switzerland. Bellevue Group consists of the subsidiaries Bellevue Asset Management, Bellevue Private Markets and StarCapital. It has 9,6 billion Swiss francs Assets Under Management Around 80% of clients assets are in healthcare investments. Bellevue Group is also active in alternative investments and private equity, including co-investments in private domestic small and medium-sized enterprises. In this business area, client assets under management were 1.0 billion francs as of mid-2021. Bellevue Group is among the largest investors in the health care segment worldwide. It has subsidiaries in Germany, UK and USA, and is focusing on platform companies with products in phase two trials or later who preferably develop technologies that can be applied in multiple ways. One of the Bellevue Asset Management teams manages the BB Biotech investment company. The former investment company BB Medtech, which was converted into an equity fund at the end of September 2009, is also managed by Bellevue Asset Management. Wikipedia
設立
1993
ウェブサイト
従業員数
88
検索
検索をクリア
検索を終了
Google アプリ
メインメニュー